ETF Exchange > BBC ETF
BBC - ETF Fact Sheet
Virtus LifeSci Biotech Clinical Trials ETF - USD
Fund Identification
Ticker
BBC
ISIN
US26923G3011
Main Metrics
Price
$53.74Expense Ratio
0.65%AuM
$51.05MTracking Difference
-2.68%Ratings
Trackinsight rating
N/AOfficial Investment Strategy
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
BBC's historical prices, performance, and flows
1m returns
10%
1m flows
$0M
* Net total returns
All data as of 2 September 2026
The ETF Exchange is brought to you by
With data and analysis by
See all BBC data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
BBC's characteristics
Manager
Manager statistics
26 funds, $2.99Bn in AUM
Benchmark
LifeSci Biotechnology Clinical Trials Total Return Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
BBC's exposure
Countries
USA
90.35%
Other
9.65%
Sectors
Healthcare
100.00%
Top 5 holdings
First Tracks Biotherapeutics, Inc.
1.57%
Monopar Therapeutics, Inc.
1.22%
MBX Biosciences, Inc.
1.14%
Zenas BioPharma, Inc.
1.09%
Xencor, Inc.
1.06%
Total holdings
127
Total weight of top 5
6.08%